Thermo Fisher Scientific Inc. (VIE:TMOF)

Austria · Delayed Price · Currency is EUR

480.35

-1.50 (-0.31%)

Last updated: Oct 22, 2025, 9:05 AM CET

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Life Sciences Solutions Revenue	10.03B	9.63B	Log In	Log In	Log In	Upgrade
Analytical Instruments Revenue	7.53B	7.46B	Log In	Log In	Log In	Upgrade
Specialty Diagnostics Revenue	4.61B	4.51B	Log In	Log In	Log In	Upgrade
Laboratory Products and Biopharma Services Revenue	23.54B	23.16B	Log In	Log In	Log In	Upgrade
Revenue (Other)	-1.98B	-1.88B	Log In	Log In	Log In	Upgrade
Revenue (Total)	43.74B	42.88B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Consumables Revenue	-	17.59B	Log In	Log In	Log In	Upgrade
Instruments Revenue	-	7.45B	Log In	Log In	Log In	Upgrade
Services Revenue	-	17.85B	Log In	Log In	Log In	Upgrade
Revenue (Total)	43.74B	42.88B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
North America Revenue	-	22.50B	Log In	Log In	Log In	Upgrade
Europe Revenue	-	10.86B	Log In	Log In	Log In	Upgrade
Asia-Pacific Revenue	-	7.96B	Log In	Log In	Log In	Upgrade
Other Regions Revenue	-	1.56B	Log In	Log In	Log In	Upgrade
Revenue (Other)	43.74B	1.00M	Log In	Log In	Log In	Upgrade
Revenue (Total)	43.74B	42.88B	Log In	Log In	Log In	Upgrade

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Life Sciences Solutions Operating Income	3.67B	3.50B	Log In	Log In	Log In	Upgrade
Analytical Instruments Operating Income	1.82B	1.96B	Log In	Log In	Log In	Upgrade
Specialty Diagnostics Operating Income	1.20B	1.16B	Log In	Log In	Log In	Upgrade
Laboratory Products and Biopharma Services Operating Income	3.25B	3.09B	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-2.44B	-2.37B	Log In	Log In	Log In	Upgrade
Operating Income (Total)	7.51B	7.34B	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Total Organic Revenue Growth	-	-	Log In	Log In	Log In	Upgrade
Core Organic Revenue Growth	-	-	Log In	Log In	Log In	Upgrade

Updated Sep 27, 2025. Data Source: Fiscal.ai.